TRIAZOLAM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triazolam and what is the scope of freedom to operate?
Triazolam
is the generic ingredient in two branded drugs marketed by Pfizer, Hikma, Norvium Bioscience, Novast Labs, Sandoz, Watson Labs, and Zydus Pharms, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.There are six drug master file entries for triazolam. Nine suppliers are listed for this compound.
Summary for TRIAZOLAM
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 7 |
NDAs: | 7 |
Drug Master File Entries: | 6 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Clinical Trials: | 19 |
Patent Applications: | 6,564 |
Drug Prices: | Drug price trends for TRIAZOLAM |
What excipients (inactive ingredients) are in TRIAZOLAM? | TRIAZOLAM excipients list |
DailyMed Link: | TRIAZOLAM at DailyMed |
Recent Clinical Trials for TRIAZOLAM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
RenJi Hospital | Phase 4 |
University of Manitoba | N/A |
Rocky Vista University, LLC | Phase 4 |
Pharmacology for TRIAZOLAM
Drug Class | Benzodiazepine |
Medical Subject Heading (MeSH) Categories for TRIAZOLAM
Anatomical Therapeutic Chemical (ATC) Classes for TRIAZOLAM
US Patents and Regulatory Information for TRIAZOLAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | TRIAZOLAM | triazolam | TABLET;ORAL | 216890-002 | Nov 8, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hikma | TRIAZOLAM | triazolam | TABLET;ORAL | 074224-001 | Jun 1, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | TRIAZOLAM | triazolam | TABLET;ORAL | 074445-002 | Oct 20, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Novast Labs | TRIAZOLAM | triazolam | TABLET;ORAL | 214219-002 | Oct 20, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Zydus Pharms | TRIAZOLAM | triazolam | TABLET;ORAL | 213003-002 | Dec 28, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Norvium Bioscience | TRIAZOLAM | triazolam | TABLET;ORAL | 074031-001 | Mar 25, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for TRIAZOLAM
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-003 | Apr 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-002 | Nov 15, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-002 | Nov 15, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-001 | Nov 15, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Pfizer | HALCION | triazolam | TABLET;ORAL | 017892-003 | Apr 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.